
|Articles|July 11, 2012
Drug Cost Control in Oncology
Panel members are asked to discuss what drives the cost of drugs in cancer care. They also discuss the role companion diagnostics and personalized medicine play in oncology.
Advertisement
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Oral PCSK9 Inhibitor Enlicitide Matches Injectables in Lowering LDL Cholesterol
2
Efficacy and Equity With Oral PCSK9s: Ann Marie Navar, MD, PhD
3
Eosinophilia Linked With Immune-Related Adverse Events in NSCLC Treatment
4
Mitigate Treatment Burden in Heart Failure: Martha Gulati, MD
5















































